Patent details

Basic Information

Publication number:

EP2442651

PCT Application Number:

PCT/US/2010/001759

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107898736

PCT Publication Number:

WO/2010/147665

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD

French Title of Invention:

TRAITEMENT DE LA SCLÉROSE EN PLAQUES PAR LE LAQUINIMOD

German Title of Invention:

BEHANDLUNG MULTIPLER SKLEROSE MIT LAQUINIMOD

SPC Number:

Dates

Filing date:

18/06/2010

Grant date:

29/07/2015

EP Publication Date:

29/07/2015

PCT Publication Date:

23/12/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/04/2012

EP B1 Publication Date:

29/07/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/06/2018

Expiration date:

18/06/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/06/2010

 

 

Name:

Teva Pharmaceutical Industries Ltd.

Address:

5 Basel Street P.O. Box 3190, 49131 Petah Tiqva, Israel (IL)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

09/09/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

TARCIC Nora

Address:

Israel (IL)

2

Name:

BAR-ZOHAR Dan

Address:

Israel (IL)

3

Name:

KOFLER Dina

Address:

Israel (IL)

Priority

Priority Number:

269070 P

Priority Date:

19/06/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

A61P 25/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

20/06/2017

Last Annual Fee Paid Number:

8

Last Annual Fee Paid Amount:

99 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages
30/10/2018	Outgoing Correspondence	1